Portolan Capital Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Buy |
1,011,844
+22,852
| +2% | +$366K | 1.02% | 33 |
|
|
2025
Q1 | $19.2M | Buy |
988,992
+74,136
| +8% | +$1.44M | 1.46% | 25 |
|
|
2024
Q4 | $20.2M | Sell |
914,856
-309,164
| -25% | -$6.81M | 1.36% | 21 |
|
|
2024
Q3 | $20.6M | Buy |
1,224,020
+203,068
| +20% | +$3.42M | 1.49% | 15 |
|
|
2024
Q2 | $12.2M | Sell |
1,020,952
-122,720
| -11% | -$1.47M | 1% | 32 |
|
|
2024
Q1 | $12.7M | Buy |
+1,143,672
| New | +$12.7M | 0.97% | 38 |
|